by TrN2016_SandWich | Apr 12, 2016 |
Philip Hedge Philip Hedge (PhD) is a bioscientist with 24 years of experience of cancer drug discovery at AstraZeneca. Philip has conducted and led research across all phases of research, including new target discovery, lead generation,...
by TrN2016_SandWich | Apr 12, 2016 |
Miri Seiberg Miri Seiberg is a life sciences R&D expert with a track record of research innovation. She has initiated and managed research and development programs in the fields of skin and mucosal tissue biology, resulting in novel drug candidates and successful...
by TrN2016_SandWich | Apr 12, 2016 |
Brendan Leighton Brendan Leighton, Ph.D., is a Biochemist who has provided professional bioscience services to the pharmaceutical industry since 1998. With more than 14 years of pharmaceutical industry experience, Dr. Leighton provides drug discovery...
by TrN2016_SandWich | Apr 12, 2016 |
Andrew Charles Andrew has more than 25 years experience in the pharmaceutical industry across all phases of drug discovery from early target identification and validation to late PhIIb. During his career in AstraZeneca, Andrew has worked as a bioscientist in several...
by TrN2016_SandWich | Apr 12, 2016 |
David Tuffin Dr. Tuffin’s area of professional expertise is the biological sciences (biochemistry / pharmacology / physiology) as applied to preclinical research and development in the pharmaceutical industry; primarily in the discovery and development of small...
